BioWorld - Friday, January 24, 2020

Liz Hollis

Articles

ARTICLES

Deal-handshake-wire-frame.png

Masimo to buy Nanthealth’s connected care business, provides estimates for 2020 guidance

January 14, 2020
By Liz Hollis
No Comments
Irvine, Calif.-based Masimo Corp. has agreed to buy the connected care assets of Nanthealth Inc., of Culver City, Calif., for a $47.25 million up-front cash payment. In addition, Masimo provided estimates for its full-year 2020 financial guidance, saying product revenue will increase to $1.035 billion, which reflects reported growth of 10.6% to 10.9%. The transaction is expected to close in the first quarter of the year, subject to customary closing conditions. In addition, Masimo expects to fund the acquisition with existing cash on hand.
Read More
1-10-sebacia.png

Sebacia names CEO, picks up Sienna assets

January 10, 2020
By Liz Hollis
No Comments
Duluth, Ga.-based Sebacia Inc., which is focused on dermatology and aesthetics, has introduced its new CEO and reported the acquisition of all assets related to Sienna Biopharmaceuticals Inc.'s silver photoparticle technology, which is being reviewed by the FDA for light hair removal.
Read More
AI-digital-dollar-coins.png
CES Digital Health Summit

Digital health funding landscape still active despite slight dip

January 9, 2020
By Liz Hollis
No Comments
What does the landscape look like in terms of funding for digital health? Geoffrey Starr, a partner at Cooley LLP, dove into this question during the Digital Health Summit, part of CES 2020. He acknowledged that 2019 saw a slight dip in funding compared with the record-breaking previous year. With that said, it was the second largest year ever for digital health care financings, with more than one-third of all health care venture financings involving digital health technologies.
Read More
1-8-Amy-Abernethy-FDA.png
CES Digital Health Summit

FDA official looks to take the mystery out of digital regulation

January 8, 2020
By Liz Hollis
No Comments
LAS VEGAS – The U.S. FDA has said it is looking to help those interested in developing digital health tools, and that commitment took center stage this week during the Digital Health Summit, part of CES 2020. Amy Abernethy, principal deputy commissioner at the FDA, gave an overview of the agency’s thinking on the topic, providing the perspective of someone who came from outside the regulatory world.
Read More
obesity-weight.png

Obesity-focused Allurion scoops up $34M in new funding

January 8, 2020
By Liz Hollis
No Comments
The obesity problem is one that is affecting a growing number of people globally. With both device and drug companies looking to take on the challenge of combating the problem, Allurion Technologies Inc. has set its sights on advancing a new approach in the U.S. Now, the Natick, Mass.-based company has scored $34 million in new funding through a securities financing and a growth capital term loan. The round was led by Novalis Lifesciences and Romulus Capital, with participation from Ido Investments and ex-Covidien CEO Jose Almeida.
Read More

Popular Stories

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe